Laurent-Puig P - Search Results

1

ERBB3-Activating Mutations in Small Bowel Adenocarcinomas.

Cabel L, Aparicio T, Bieche I, Svrcek M, Zaanan A, Afchain P, Di Fiore F, Gornet JM, Le Corre D, Vacher S, Callens C, Bernard V, Laurent-Puig P, Bidard FC. Cabel L, et al. JCO Precis Oncol. 2018 Nov;2:1-9. doi: 10.1200/PO.17.00243. JCO Precis Oncol. 2018. PMID: 35135114

2

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Lièvre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, Côté JF, Tomasic G, Penna C, Ducreux M, Rougier P, Penault-Llorca F, Laurent-Puig P. Lièvre A, et al. Cancer Res. 2006 Apr 15;66(8):3992-5. doi: 10.1158/0008-5472.CAN-06-0191. Cancer Res. 2006. PMID: 16618717

3

Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.

Blons H, Côté JF, Le Corre D, Riquet M, Fabre-Guilevin E, Laurent-Puig P, Danel C. Blons H, et al. Am J Surg Pathol. 2006 Oct;30(10):1309-15. doi: 10.1097/01.pas.0000213285.65907.31. Am J Surg Pathol. 2006. PMID: 17001163

4

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, Ychou M, Bouché O, Landi B, Louvet C, André T, Bibeau F, Diebold MD, Rougier P, Ducreux M, Tomasic G, Emile JF, Penault-Llorca F, Laurent-Puig P. Lièvre A, et al. J Clin Oncol. 2008 Jan 20;26(3):374-9. doi: 10.1200/JCO.2007.12.5906. J Clin Oncol. 2008. PMID: 18202412

5

No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.

Pallier K, Houllier AM, Le Corre D, Cazes A, Laurent-Puig P, Blons H. Pallier K, et al. Mol Carcinog. 2009 Jul;48(7):581-5. doi: 10.1002/mc.20538. Mol Carcinog. 2009. PMID: 19353596

6

Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment.

Aparicio T, Zaanan A, Svrcek M, Laurent-Puig P, Carrere N, Manfredi S, Locher C, Afchain P. Aparicio T, et al. Dig Liver Dis. 2014 Feb;46(2):97-104. doi: 10.1016/j.dld.2013.04.013. Epub 2013 Jun 21. Dig Liver Dis. 2014. PMID: 23796552 Free article. Review.

7

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Aparicio T, Svrcek M, Zaanan A, Beohou E, Laforest A, Afchain P, Mitry E, Taieb J, Di Fiore F, Gornet JM, Thirot-Bidault A, Sobhani I, Malka D, Lecomte T, Locher C, Bonnetain F, Laurent-Puig P. Aparicio T, et al. Br J Cancer. 2013 Dec 10;109(12):3057-66. doi: 10.1038/bjc.2013.677. Epub 2013 Nov 5. Br J Cancer. 2013. PMID: 24196786 Free PMC article.

8

[MET signalling pathway and its therapeutic implications in gastrointestinal cancers].

Zaanan A, Laurent-Puig P, Taieb J. Zaanan A, et al. Bull Cancer. 2014 Jan 1;101(1):25-30. doi: 10.1684/bdc.2013.1870. Bull Cancer. 2014. PMID: 24445683 Review. French.

9

Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'.

Tougeron D, Laurent-Puig P, Zaanan A. Tougeron D, et al. Br J Cancer. 2014 Dec 9;111(12):2379-80. doi: 10.1038/bjc.2014.114. Epub 2014 Mar 11. Br J Cancer. 2014. PMID: 24619075 Free PMC article. No abstract available.

10

ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.

Laforest A, Aparicio T, Zaanan A, Silva FP, Didelot A, Desbeaux A, Le Corre D, Benhaim L, Pallier K, Aust D, Pistorius S, Blons H, Svrcek M, Laurent-Puig P. Laforest A, et al. Eur J Cancer. 2014 Jul;50(10):1740-1746. doi: 10.1016/j.ejca.2014.04.007. Epub 2014 May 2. Eur J Cancer. 2014. PMID: 24797764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters